Bifidobacterium longum
Bifidobacterium longum is a well-characterized commensal species found throughout the human gut, with a particularly studied role in early-life microbiome establishment. The available evidence base for this strain is early-stage and varied: in vitro studies have explored enzyme activity, sulfur metabolism, and colon cancer cell lines, while animal model research has examined gut barrier function and inflammatory cytokines in colitis contexts. One observational study examines how diet and milk glycans influence B. longum subspecies dynamics in the infant gut microbiome. No human clinical trials appear in this strain's evidence set. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 2,472 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 827 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
3793 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →The impact of probiotics on gut health and immune system modulation: A comprehensive study· Journal of Advances in Microbiology Research · 2026
-
[2]
PMID 41799757 →Effect of Bifidobacterium longum on cognition and microbiota in post-stroke patients: a single-blinded, controlled trial· International Journal of Medical Sciences · 2026
-
[3]
PMID 42047238 →Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial· Allergy · 2026
-
[4]
PMID 41523285 →Probiotic Supplementation With Bifidobacterium longum Subsp. Longum BL21 Improves Glycemic Control and Modulates Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial· Food Science & Nutrition · 2026
-
[5]
PMID 41682832 →Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome· Journal of Clinical Medicine · 2026
-
[6]
Source →Adjunctive Bifidobacterium longum SX-1326 improves the therapeutic efficacy of Acupotomy in post-stroke dysphagia: A randomized, double-blind, placebo-controlled study· Journal of Functional Foods · 2026
-
[7]
Source →Targeting the “gut-immune axis”: Bifidobacterium longum subsp. infantis CCFM111 serves as a novel therapeutic for pediatric allergic rhinitis· Food Science and Human Wellness · 2026
-
[8]
PMID 39940249 →Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review· Nutrients · 2025
-
[9]
PMID 40817120 →Strain specific effects of probiotic supplementation on serum amino acid profiles in Alzheimer’s disease: a randomized, double blind, placebo controlled trial· Scientific Reports · 2025
-
[10]
PMID 40442154 →Integrated multi-omics reveals different host crosstalk of atopic dermatitis-enriched Bifidobacterium longum Strains· npj Biofilms and Microbiomes · 2025